Aris Persidis

Aris Persidis

Company: Biovista

Job title: President

Seminars:

Chair’s Opening Remarks 8:55 am

Read more

day: Day Two

Chair’s Closing Remarks & End of Conference 4:30 pm

Read more

day: Day Two

Panel Discussion – Commercial Sustainability in New Indication Discovery 11:45 am

The commercial balancing act of drug repurposing – benefit the patients in the best possible fashion whilst sustaining a businessRead more

day: Day Two

Case Study – Not All AIs Are Created Equal for Repositioning: Balancing Benefit & Risk Outcomes 2:30 pm

• Repositioning includes not just finding a new benefit for an existing drug, but equally ensuring its safety in the unanticipated disease. Any method (AI or otherwise) to reposition should be equally good at both • Not all AI’s are created equal: to machine learning (ML) AI, everything is a ML problem (to a hammer,…Read more

day: Day Two

Panel Discussion – Repurposing Prominence During Covid-19 9:00 am

Drug repurposing has shone during the pandemic, but will the lessons learned translate into a more organized response for future pandemics?Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.